Blog
RSS FeedPosted by Michael Wonder on 08 Oct 2018
Liberals accused of caving on drug 'concession' at request of U.S.
4 October 2018 - The Trudeau Liberals are being accused of caving in to pressure from the high-powered pharmaceutical industry ...
Posted by Michael Wonder on 08 Oct 2018
Revised process for ultra-orphan medicines
8 October 2018 - Following the Scottish Government's announcement around a new pathway in June 2018, a new approach to the ...
Posted by Michael Wonder on 08 Oct 2018
SMC - October 2018 decisions
8 October 2018 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice accepting ...
Posted by Michael Wonder on 08 Oct 2018
Who knows the true cost of medicines?
1 October 2018 - PHARMAC director of operations Lisa Williams says the drug-buying system delivers good value for Kiwis, even though ...
Posted by Michael Wonder on 08 Oct 2018
The high cost of living for advanced breast cancer patients
6 October 2018 - Donna MacMillan: ''I feel as if the Government doesn't care whether I live or die. That I ...
Posted by Michael Wonder on 08 Oct 2018
New Zealand women with advanced breast cancer are dying faster than in other countries
6 October 2018 - Wiki Mulholland, 40 is calling for Ibrance to be funded by PHARMAC so more women can access ...
Posted by Michael Wonder on 08 Oct 2018
Request for proposals for PHARMAC and HRC research partnership 2019
8 October 2018 - PHARMAC and the Health Research Council of New Zealand request research proposals. ...
Posted by Michael Wonder on 08 Oct 2018
Family pleads with PHARMAC to help save toddler's life by funding cystic fibrosis ‘wonder drug’
8 October 2018 - Sixteen-month-old Otis Porter's parents are pleading for Kalydeco to be funded, to help the toddler live. ...
Posted by Michael Wonder on 08 Oct 2018
NICE expands backing for Pfizer’s Mylotarg
8 October 2018 - NICE is recommending Mylotarg for previously untreated, de novo, CD33-positive acute myeloid leukaemia in combination with ...
Posted by Michael Wonder on 08 Oct 2018
Committee recommends against funding $250,000-a-year Orkambi cystic fibrosis drug
4 October 2018 - Canadian governments should not pay for a $250,000-a-year cystic fibrosis medication because it is not clear ...
Posted by Michael Wonder on 07 Oct 2018
How drug treatment in Hong Kong changed Aussie cancer sufferer’s life
7 October 2018 - When Lisa Laird was diagnosed with metastatic cancer, she found hope in a new drug she could ...
Posted by Michael Wonder on 06 Oct 2018
Global moves to reduce the future cost of publicly funded medicines
5 October 2018 - The most significant advances in medical treatments are being made with biological products that are significantly ...
Posted by Michael Wonder on 05 Oct 2018
Gilead strikes deal with NHS England on CAR-T Yescarta
5 October 2018 - NHS England claims adult leukaemia access is first in Europe. ...
Posted by Michael Wonder on 05 Oct 2018
MHRA consults on new regulatory framework for ‘no-deal’ scenario
5 October 2018 - The Medicines and Healthcare products Regulatory Agency has launched a consultation seeking views on how its ...
Posted by Michael Wonder on 04 Oct 2018
NICE publishes draft guidance for idelalisib
4 October 2018 - The Department of Health and Social Care has asked the NICE to produce guidance on using idelalisib ...